Literature DB >> 1624248

Influence of antiplatelet drugs on occlusion of arteriovenous fistula in uraemic patients.

K Janicki1, A Dmoszyńska, L Janicka, S Stettner, J Jesipowicz.   

Abstract

A long-standing arteriovenous (A-V) fistula may develop thrombotic complications. In 20 patients on intermittent peritoneal dialysis (IPD) arteriovenous fistula was made surgically. We evaluated the efficacy of three antiplatelet drugs: Ibustrin (Group A), sulphinpyrazone (Group B) and alpha-tocopherol (Group C) in preventing thrombotic occlusion of A-V fistulas. Results of the trial indicate that the three drugs significantly reduce spontaneous platelet aggregation and ADP induced aggregation. The heparin neutralizing activity was significantly increased during treatment. Significant prolongation of bleeding time was observed only in Groups B and C. In patients receiving antiplatelet drugs no occlusion of A-V fistulas was observed. In the control group such complications occurred in 3 of the 20 patients. Our results indicate that antiplatelet drugs by inhibiting the platelet function may prevent thrombotic occlusions of A-V fistulas in IPD patients.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1624248     DOI: 10.1007/bf02552122

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  12 in total

1.  Aggregation of blood platelets by adenosine diphosphate and its reversal.

Authors:  G V BORN
Journal:  Nature       Date:  1962-06-09       Impact factor: 49.962

2.  A new method for the quantitative detection of platelet aggregates in patients with arterial insufficiency.

Authors:  K K Wu; J C Hoak
Journal:  Lancet       Date:  1974-10-19       Impact factor: 79.321

3.  Beta-thromboglobulin and platelet factor 4 plasma levels during haemodialysis: effect of indobufen.

Authors:  E M Pogliani; M Colombi; G Cristoforetti; G Valenti; R Miradoli; G Buccianti
Journal:  Pharmatherapeutica       Date:  1982

4.  Platelet dysfunction and its life span in uremia.

Authors:  H Tanaka; K Uminoto; N Izumi; K Nishimoto; H Yoshihara; Y Katoh; T Kishimuto; M Maekawa
Journal:  Trans Am Soc Artif Intern Organs       Date:  1984

5.  Sonography of arteriovenous fistulae in hemodialysis patients.

Authors:  M Weber; F P Kuhn; W Quintes; E Keidl; H Köhler
Journal:  Clin Nephrol       Date:  1984-11       Impact factor: 0.975

6.  Microthrombus formation on hemodialysis membranes: a placebo controlled randomized trail of two doses of Indobufen.

Authors:  M C Salter; P Mayor; M J Crow; S M Rajah; A M Davison
Journal:  Clin Nephrol       Date:  1985-07       Impact factor: 0.975

7.  Occlusive arterial disease in uraemic and haemodialysis patients and renal transplant recipients. A study of the incidence of arterial disease and of the prevalence of risk factors implicated in the pathogenesis of arteriosclerosis.

Authors:  L S Ibels; J H Stewart; J F Mahony; F C Neale; A G Sheil
Journal:  Q J Med       Date:  1977-04

8.  The effect of sulphinpyrazone and its metabolites on platelet function in vitro and ex vivo.

Authors:  G F Pay; R B Wallis; D Zelaschi
Journal:  Haemostasis       Date:  1981

9.  Intravenous streptokinase for thrombolysis of occluded arteriovenous access. Its use in patients undergoing hemodialysis.

Authors:  J P Goldberg; S R Contiguglia; J L Mishell; M H Klein
Journal:  Arch Intern Med       Date:  1985-08

10.  Effect of vitamin E on platelet aggregation in diabetes mellitus.

Authors:  J Watanabe; F Umeda; H Wakasugi; H Ibayashi
Journal:  Thromb Haemost       Date:  1984-07-29       Impact factor: 5.249

View more
  4 in total

1.  Randomized controlled trial of clopidogrel to prevent primary arteriovenous fistula failure in hemodialysis patients.

Authors:  A Ghorbani; M Aalamshah; H Shahbazian; A Ehsanpour; A Aref
Journal:  Indian J Nephrol       Date:  2009-04

2.  Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial.

Authors:  Laura M Dember; Gerald J Beck; Michael Allon; James A Delmez; Bradley S Dixon; Arthur Greenberg; Jonathan Himmelfarb; Miguel A Vazquez; Jennifer J Gassman; Tom Greene; Milena K Radeva; Gregory L Braden; T Alp Ikizler; Michael V Rocco; Ingemar J Davidson; James S Kaufman; Catherine M Meyers; John W Kusek; Harold I Feldman
Journal:  JAMA       Date:  2008-05-14       Impact factor: 56.272

3.  Ticlopidine to prevent primary arteriovenous fistula failure in hemodialysis patients; a randomized controlled trial.

Authors:  Ali Ghorbani; Farzad Jasemi-Zergani
Journal:  J Renal Inj Prev       Date:  2013-09-01

4.  Oral prostacycline analog and clopidogrel combination provides early maturation and long-term survival after arteriovenous fistula creation: A randomized controlled study.

Authors:  A F Abacilar; H Atalay; O F Dogan
Journal:  Indian J Nephrol       Date:  2015 May-Jun
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.